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Background: Mortierella alpina is an oleaginous fungus used in the industrial scale production of arachidonic acid
(ARA). In order to investigate the metabolic characteristics at a systems level and to explore potential strategies for
enhanced lipid production, a genome-scale metabolic model of M. alpina was reconstructed.
Results: This model included 1106 genes, 1854 reactions and 1732 metabolites. On minimal growth medium,
86 genes were identified as essential, whereas 49 essential genes were identified on yeast extract medium. A series
of sequential desaturase and elongase catalysed steps are involved in the synthesis of polyunsaturated fatty acids
(PUFAs) from acetyl-CoA precursors, with concomitant NADPH consumption, and these steps were investigated in
this study. Oxygen is known to affect the degree of unsaturation of PUFAs, and robustness analysis determined that
an oxygen uptake rate of 2.0 mmol gDW−1 h−1 was optimal for ARA accumulation. The flux of 53 reactions involving
NADPH was significantly altered at different ARA levels. Of these, malic enzyme (ME) was confirmed as a key component
in ARA production and NADPH generation. When using minimization of metabolic adjustment, a knock-out of ME led to
a 38.28% decrease in ARA production.
Conclusions: The simulation results confirmed the model as a useful tool for future research on the metabolism
of PUFAs.
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Malic enzymeBackground
Mortierella alpina is an oleaginous zygomycete, that can
accumulate lipids to 50% of its dry weight in the form of
triacylglycerols [1]. The important ω-6 polyunsaturated
fatty acid (PUFA) arachidonic acid (ARA) can account for
over 50% of the lipid content [2]. M. alpina is nonpatho-
genic and nonallergenic, including the spores produced
during the industrial production of ARA [3] which is
widely used in food ingredients [4]. ARA has been pro-
duced at levels up to 19.8 g/L in 5 L cultures grown over
7 days [5]. Various methods have been attempted in
order to improve ARA production including screening* Correspondence: mingll@jiangnan.edu.cn
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unless otherwise stated.potentially higher yielding mutant strains following
treatment with N-methyl-N’-nitro-N-nitrosoguanidine
(MNNG) [6]. This work led to the generation of M.
alpina strain Y11 which possessed lowered ω-3 de-
saturation activity, and ARA production was 2.1 fold
(2.21 g/L) higher than strain 1S-4. Optimizing the culture
medium and fixing the ratio of defatted soybean meal to
potassium nitrate at 2:1 gave a fourfold increase (6.0 g/L)
in ARA production [7]. In another study the fermentation
process was optimized, and a two-stage temperature-shift
strategy increased ARA production by 26.1% (9.2 g/L) [8].
Additionally, overexpressing GLELO gene using a genetic
manipulation approach increased ARA production by
101.2% (5.05 g/L) [9].
Genetic engineering of M. alpina for enhanced ARA
production remains an attractive proposition and for
further research. Early work identified desaturases as key
enzymes in PUFA synthesis. Specifically, Δ5 desaturaseis an Open Access article distributed under the terms of the Creative Commons
rg/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Table 1 General features of model iCY1106
Features iCY1106 Existed modela
Genome feature
Genome size (Mb) 38.38 38.38
Total open reading frames (ORFs) 11631 11631
Metabolic model
Total reactions 1854 1183
Biochemical reactions 1391 1183
Transport reactions 247 none
Exchange reactions 216 none
Metabolites 1732 1660
ORFs associated in model 1106 1042
ORF coverageb (%) 9.51 8.95
aThe existed model was constructed by Vongsangnak et al. [21]; bThe number
of ORFs incorporated in model iCY1106 divided by the total number of ORFs.
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linolenic acid (DGLA) to form ARA, was isolated and
functionally characterized. The rate-limiting step for
ARA biosynthesis is catalyzed by elongase which con-
verts γ-linolenic acid (GLA) to DGLA [11,12]. NADH-
cytochrome b5 reductase (Cb5R), an electron carrier
and a major component of the cytochrome b5-dependent
electron transport system, is also crucial. Cb5R catalyzes
several different reduction reactions, including the de-
saturation and elongation of acyl chains built from acetyl-
CoA during PUFA synthesis [13]. Despite various studies
that have identified the importance of these enzymes in
PUFA synthesis and metabolism [2,14], their exact roles
are not completely understood, and neither are the path-
ways through which glucose relates to PUFA biosynthesis
and metabolism.
A genome-scale metabolic model (GSMM) is an in-
dispensable tool for the study of metabolism that adopts
a systems biology approach to integrate data from gen-
omics, transcriptomics, proteomics and metabolomics. It
has been widely used in the analysis of the network
properties of metabolism [15], prediction and analysis of
organism growth phenotypes [16], model-based interpret-
ation of experimental data [17], and metabolic engineering
[18]. Oleaginous organisms such as M. alpina can accu-
mulate large quantities of lipids, but maximizing lipid pro-
duction is complicated by the complexity of the regulatory
mechanisms associated with lipid metabolism. It is gener-
ally difficult to identify key metabolic modules contribut-
ing to lipid physiology. Using reconstruction GSMM, we
can systematically analyze the function of each gene and
metabolic reaction and model the effects using flux bal-
ance analysis (FBA). Specific pathways can be understood
based on the model of the whole metabolic network, and
strain design strategies can also be used to guide meta-
bolic engineering experiments. Two GSMM studies on
Yarrowia lipolytica (iNL895 [19] and iYL619_PCP [20])
have been published along with recent modeled networks
of Mucor circinelloides and M. alpina [21]. GSMM studies
therefore provide a new approach to investigating the
complex lipid metabolism in M. alpina. Vongsangnak
et al. (2013) [21] previously published a M. alpina
network model, however, this was a refined network
that could only be used to investigate genome annota-
tion and metabolic routes, and not flux distribution or
phenotypic behaviors [21]. To systematically study flux
distribution and the mechanism of lipid accumulation,
we reconstructed a new M. alpina GSMM and used
the COBRA Toolbox [22] for subsequent research.
In this study, a genome-scale metabolic model
(iCY1106) of M. alpina ATCC 32222 was reconstructed
based on sequencing results [2]. Using this model, we
first identified essential genes and reactions in fermen-
tation medium containing sodium nitrate as a nitrogensource [23]. The de novo synthesis pathways of PUFAs
such as ARA and eicosapentaenoic acid (EPA) were subse-
quently resolved. The roles of acetyl-CoA and NADPH
in the regulation of PUFA biosynthesis were probed,
and important genes and reactions were systematically
analyzed using FBA, flux variability analysis (FVA), and
minimization of metabolic adjustment (MOMA).
Results and discussions
Characterization of the M. alpina GSMM iCY1106
The genome-scale metabolic model iCY1106 recon-
structed in this study included 1106 genes representing
9.51% of the 11631 protein-coding genes in the genome
of M. alpina ATCC 32222. The model consisted of 1854
reactions and 1732 metabolites (Table 1). Compared
with the previous model constructed by Vongsangnak
[21], iCY1106 is more detailed and contains a higher
degree of functional information that can be used in in
silico simulations. During the construction of iCY1106,
some missing gene were added from the Vongsangnak’s
model such as MA-090-247, which encodes an aspara-
ginase (EC: 3.5.1.1), and catalyzes the transformation
of L-asparagine into L-aspartate. When compared with
the existing model, many improvements in iCY1106
are apparent. (1) A total of 139 transport proteins were
annotated based on TCDB and TransportDB. (2) A
total of 216 exchange reactions were added into model
iCY1106. (3) Biomass composition of M. alpina was
calculated based on literature mining. (4) Additional
chemical reactions were also included. (5) The reversibility
of some reactions was redefined according to MetaCyc
and BioPath databases. For example, in the published
model, the reaction catalyzed by aldehyde dehydrogenase
(EC: 1.2.1.3) was reversible, whereas this reaction is ir-
reversible according to BioPath. The flux distribution of
iCY1106 was normal following this change.
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cytoplasmic, peroxisome and mitochondrial compartments)
were linked by 141 trans-plasma membrane transport
reactions, 98 cytoplasmic-mitochondrial transport reac-
tions and eight cytoplasmic-peroxisome transport reac-
tions (Additional file 1). The extracellular compartment
contained 267 reactions, including 216 exchange reactions
and 51 metabolic reactions. These metabolic reactions cat-
alyzed by extracellular enzymes may enable M. alpina to
adapt to different environmental conditions. For example,
M. alpina grows on different carbohydrates such as gly-
cerol [24], sucrose [24], d-mannose [25], and raffinose
[25] using various extracellular galactosidases. The peroxi-
some compartment contained 34 reactions mostly related
to glyoxylate metabolism.
Metabolic reactions in the model iCY1106 were divided
into ten metabolic subsystems (Figure 1). The largest sub-
system was lipid metabolism (fatty acid biosynthesis, fatty
acid elongation, steroid, glycerolipid, glycerophospholipid
and sphingolipid metabolism) that accounted for 23.53%
of the total reactions. Reactions involving the synthesis of
PUFAs such as DGLA, ARA, and EPA are listed in model
iCY1106. For most subsystems, most categories were
more abundant in iCY1106 than in the Vongsangnak’s
model, with the exception of Amino Acid Metabolism and
Nucleotide Metabolism (Figure 1a). Since there were six
compartments (cytosol, mitochondria, peroxisome, extra-
cellular, plasma membrane and unclassified compartment)
in Vongsangnak’s model, some reactions occur in multiple
compartments at the same time. When ignoring com-
partments, not including transport reactions and ex-
change reactions, these two models shared 566 reactions
(Additional file 2). Vongsangnak’s model and iCY1106
included 179 and 621 unique reactions, respectively
(Figure 1b). Compared with model iYL619_PCP of the
oleaginous yeast Y. lipolytica [20], lipid metabolism
accounted for a higher proportion (16.7%, 191 of total
1142 reactions) of reactions in iCY1106. Amino acid
and carbohydrate metabolism subsystems were 13.17%
and 11.66%, respectively, in iCY1106.Figure 1 The comparison between Vongsangnak’s model and iCY110
b: shared reactions and unique reactions between models.Identification of essential genes and reactions in iCY1106
When cultured on minimal growth medium (MG) con-
taining glucose, KH2PO4, MgSO4 and NaNO3 [23], 86
M. alpina genes (7.78% of the total) were identified as
essential for growth using the FBA method (Additional
file 3). In contrast, on yeast extract (YE) medium
(based on MG but including all 20 regular amino acids)
only 49 genes were identified as essential. On MG
medium, over half of the essential genes were involved
in amino acid (36.05%) and nucleotide metabolism
(23.26%; Figure 2). However on YE medium, most of
the essential genes were associated with nucleotide
metabolism (38.78%).
The identified genes were compared with the database
of essential genes (DEG), and 40 genes were found to
share high homology with genes identified by DEG
(identity ≥ 40%, E-value ≤ 1.0E-30; Table 2). One gene,
UTP-glucose-1-phosphate uridylyltransferase (MA-090-
485), is involved in the synthesis of the cell wall compo-
nent 1,3-beta-D-glucan (Table 2). MA-090-485 is highly
homologous with the Saccharomyces cerevisiae enzyme
(sequence identity = 62.58%, e-value = 0) identified in the
DEG search. Similarly, nucleoside diphosphate kinase
(MA-120-261), which is involved in the synthesis of
CTP and GTP, also shared high homology with one of
the essential genes identified by DEG (identity = 66.89%,
e-value = 2.0E-68). Besides, in MG, there were 46 genes
that did not match with DEG (Additional file 3). Of
these, when nitrate was used as nitrogen source, nitrate
reductase (MA-291-2) and nitrite reductase (MA-291-3),
which together convert nitrate into NH3 for cell growth,
were essential under this condition. Another two essen-
tial genes, delta 5 desaturase (MA-326-160) and delta
12 desaturase (MA-334-414) are vital for the synthesis
of ARA in M. alpina. In addition, most of these essential
genes were distributed in the Amino Acid Metabolism
category (28.3%). This was understandable since essen-
tial gene identified by DEG were in a rich medium in
which genes involving amino acid synthesis may not be
essential.6. a: reaction distribution in subsystems between these two models;
Figure 2 Essential genes identified by MG and YE medium in model iCY1106.
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FBA with constraints was used to investigate the meta-
bolic properties of model iCY1106. YE medium was used
to simulate the growth rate and ARA production, the
maximum uptake rate of all 20 amino acids were set at
0.01 mmol gDW−1 h-1 [26], and the glucose consumption
rate was set at 0.8 mmol gDW−1 h-1 [8], and 2.0 mmol
gDW−1 h-1 [1] respectively, and the in silico growth rate
were closed to experimental values (differences were only
0.8% and 9.48%; Table 3). To investigate ARA production
in silico, the growth rate was fixed at 0.03 h-1 [8], and the
ARA exchange reaction was set as the objective function.
Under these conditions, the ARA rate was 0.128 mmol
gDW−1 h−1 by FBA. This in silico value was lower than
the experimentally determined value of 0.149 mmol
gDW−1 h−1 (14.09%) [8], and this may due to the use of
two different M. alpina strains (ATCC 32222 and ME-1)
for modeling and experimental components, with ME-1
being the higher ARA producing strain [27]. Furthermore,
the difficulties associated with accurately modeling the
yeast extract may have resulted in a nutritional deficiency
in the model.
The capability of utilizing 14 different carbon sources
for cell growth was qualitatively predicted by the model
iCY1106 using FBA (Additional file 4). Each substance
was the sole carbon source and the rate of uptake was
1.0 mmol gDW−1 h−1. Initially, there were four types of
carbon source (ethanol, xylose, maltose, and rhamnose),
and the model could not achieve growth with any individ-
ual carbon source. For ethanol, the reaction catalyzed by
alcohol dehydrogenase (EC: 1.1.1.1) was irreversible, but
should be reversible according to the MetaCyc database.
For rhamnose, the lack of L-rhamnulose-1-phosphate
lactaldehyde-lyase (EC: 4.1.2.19) meant that rhamnose
could not generate glycerone phosphate, which could
otherwise be used by the glycolysis pathway. After
elimination of initial discrepancies using the continu-
ous gap filling process, a 100% match was acquired.This indicated that model iCY1106 could predict catabolic
pathways of various carbon sources including common
sugars and alcohols. A similar FBA simulation of nitrogen
sources (ammonium, nitrate, urea, and amino acids) also
generated results that were consistent with experimental
fermentation data. Both glutamate and glycine supported
M. alpina growth, confirming that the model performed
well for predicting the utilization of different carbon and
nitrogen sources.
PUFA biosynthetic pathways based on GSMM
To further investigate the pathways associated with PUFA
biosynthesis and metabolism, genome annotation, litera-
ture mining and KEGG database analysis were performed.
ARA is a ω-6 PUFA synthesized by M. alpina (Figure 3).
ARA (c204(6)) is synthesized from acetyl-CoA in 38 en-
zymatic steps, including the de novo synthesis of palmitic
acid (c160) and the synthesis of very long chain fatty acids.
During PUFA biosynthesis, all fatty acids should be in the
form of acyl-CoA [2]. Desaturase and elongase were ne-
cessary for the conversion of octadecanoyl-CoA (c180coa)
to ARA. Δ9 desaturase [28] (MA-055-51, MA-101-533,
MA-184-235), Δ12 desaturase [29] (MA-334-414) and Δ6
desaturase [30,31] (MA-268-54, MA-101-36) catalyzed
the conversion of c180coa into γ-linolenoyl-CoA (c183(6)
coa) which was subsequently lengthened to 8,11,14-
eicosatrienoyl-CoA (c203(6)coa) by an elongase such as
ELO/GLELO [30] (MA-189-257), MAELO [32] (MA-
184-206) or MALCE1 [33] (MA-073-327, MA-320-221).
Δ5 desaturase [10] (MA-326-160) catalyzed c203(6)coa to
arachidonyl-CoA (c204(6)coa), which was finally hydro-
lyzed to c204(6) by choloyl-CoA hydrolase (MA-049-4,
MA-139-47).
M. alpina is capable of producing ARA and EPA, and
EPA can be produced via the ω-3 or the ω-6 PUFA biosyn-
thetic pathways through ARA desaturation [34]. During
EPA biosynthesis, Δ15 (ω3) desaturase (MA-072-10) is the
key enzyme and was the first fungal desaturase known
Table 2 Essential genes identified on different mediums which are high homology with DEG
Gene Enzyme Essentiality Subsystem
MG YE
MA-133-4 Ribose-5-phosphate isomerase E E Carbohydrate metabolism
MA-090-485 UTP-glucose-1-phosphate uridylyltransferase E E
MA-101-200 Mannose-6-phosphate isomerase E E
MA-120-141 Phosphoacetylglucosamine mutase E E
MA-184-380 Acetyl-CoA carboxylase E E
MA-072-196 Argininosuccinate lyase E NE Amino acid metabolism
MA-213-50 Adenylosuccinate synthase E E
MA-213-539 Adenylosuccinate lyase E E
MA-326-6 Aspartate carbamoyltransferase E E
MA-334-434 Phosphoribosylanthranilate isomerase E NE
MA-120-148 2-Acetolactate methylmutase E NE
MA-090-434 Dihydroxy-acid dehydratase E NE
MA-139-331 Homoaconitate hydratase E NE
MA-323-77 Saccharopine dehydrogenase E NE
MA-326-106 Ornithine carbamoyltransferase E NE
MA-101-393 Imidazole-4-carboxamide isomerase E NE
MA-184-558 Imidazoleglycerol-phosphate dehydratase E NE
MA-090-452 Glutamine amidotransferase:cyclase E NE
MA-320-159 3-dehydroquinate synthase E NE
MA-139-157 Chorismate synthase E NE
MA-073-62 3-deoxy-7-phosphoheptulonate synthase E NE
MA-213-547 Tryptophan synthase E NE
MA-297-40 Chorismate mutase E NE
MA-120-157 Thioredoxin reductase E E
MA-173-30 Purine-nucleoside phosphorylase E E Nucleotide metabolism
MA-213-65 IMP dehydrogenase E E
MA-120-261 Nucleoside diphosphate kinase E E
MA-139-347 Guanylate kinase E E
MA-120-138 Ribonucleoside-diphosphate reductase E E
MA-055-211 Ribonucleoside-diphosphate reductase E E
MA-323-58 Ribonucleoside-diphosphate reductase E E
MA-334-356 Thymidylate synthase E E
MA-153-455 3(2),5-bisphosphate nucleotidase E NE
MA-111-23 phosphoadenylyl-sulfate reductase E NE Energy metabolism
MA-182-360 6,7-dimethyl-8-ribityllumazine synthase E E Cofactors and vitamins
MA-184-368 Riboflavin synthase E E
MA-210-311 Aspartate dehydrogenase E E
MA-055-340 Fatty-acyl-CoA synthase E E Lipid metabolism
MA-162-131 Palmitoyl-protein thioesterase E E
MA-334-239 Very-long-chain enoyl-CoA reductase E E
E: essential gene; NE: non-essential gene. MG: minimal medium; YE: yeast extract medium.
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Growth rate (h−1) Ref.
in vivo in silico
Glc (v = 0.8) 0.0696 0.0690 [8]
Glc (v = 2.0) 0.1708 0.1546 [1]
in vivo: experimental results; in silico: simulation results.
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substrates [35]. In the ω-3 pathway, (11Z,14Z,17Z)-icosa-
trienoyl-CoA (c204(3)coa) was used as substrate, while the
ω-6 pathway utilized c204(6)coa.
Both the maximum and minimum flux of oxygen ab-
sorption of DGLA, ARA and EPA production in silico
were found to be 1.552, 1.674 and 1.891 mmol gDW−1 h−1
respectively, using FVA. This indicated that the degree of
PUFA unsaturation was dependent on oxygen content.
Robustness analysis was used to elucidate the effects of
oxygen uptake rate on PUFA biosynthesis. The oxygen up-
take rate was perturbed by constraints-based flux analysis
between 0 and 20 mmol gDW−1 h−1. The minimum
growth rate was set at 0.03 h−1, with ARA exchange reac-
tion as the objective function. When oxygen absorption
was lower than 2.0 mmol gDW−1 h−1, ARA production in-
creased with oxygen absorption rate (Additional file 5a).
However, beyond this range, ARA production gradually
declined with increasing oxygen uptake rate. As reportedFigure 3 Synthesis pathway of PUFAs in M. alpina. (accoa: acetyl-CoA, acp:
malacp: malonyl-[acp], aacacp: acetoacetyl [acp], c4hacp: (3R)-3-Hydroxybutan
3-oxohexanoyl-[acp], c6hacp: 3-hydroxyhexanoyl-[acp], c6dacp: hex-2-enoyl-[a
3-hydroxyoctanoyl-[acp], c8dacp: oct-2-enoyl-[acp], c80acp: octanoyl-[acp], c1
dec-2-enoyl-[acp], c100acp: decanoyl-[acp], c12oacp: 3-oxododecanoyl-[acp],
c120acp: dodecanoyl-[acp], c14oacp: 3-oxomyristoyl-[acp], c14dacp: tetradec-
c16oacp: 3-oxohexadecanoyl-[acp], c16hacp: (3R)-3-Hydroxypalmitoyl-[acp], c1
palmitic acid, c160coa: hexadecanoyl-CoA, c180coa: octadecanoyl-CoA, c181c
Linolenoyl-CoA, c203(6)coa: 8,11,14-Eicosatrienoyl-CoA, c204(6)coa: Arachidon
Stearidonoyl-CoA, c204(3)coa: (11Z,14Z,17Z)-Icosatrienoyl-CoA, c205(3)coa: eic
CoA, c245(3)coa: (9Z,12Z,15Z,18Z,21Z)-Tetracosaheptaenoyl-CoA, c246(3)coa: (
c226(3)coa: (4Z,7Z,10Z,13Z,16Z,19Z)-Docosahexaenoyl-CoA).by Higashiyama et al., when the DO concentration range
was 10-15 ppm, the ARA yield was enhanced 1.6-fold over
a DO of 7 ppm, and a DO between 20 and 50 ppm dras-
tically decreased ARA production [36]. This indicated that
excessive oxygen exposure during fermentation could im-
pair ARA overproduction. During ARA biosynthesis, high
oxygen concentrations may affect metabolism and cell
growth in the filamentous mycelia, and beta-oxidation of
fatty acids may be needed to obtain the extra energy re-
quired for adaptation to the high oxygen conditions.
Regulation of PUFA biosynthesis and metabolism based
on GSMM
Acetyl-CoA is the essential two-carbon donor molecule
for fatty acid synthesis. In model iCY1106, there were
ten pathways that could produce acetyl-CoA, including
amino acid degradation (from aspartate, isoleucine, leu-
cine, and lysine), fatty acid beta-oxidation, and other
acetyl-CoA generation processes (phosphoenolpyruvate
[PEP], malate, L-lactate, acetate, and citrate) (Figure 4).
However, only the pathway from PEP to pyruvate could
generate sufficient flux for synthesis of PUFAs on the
fermentation medium. During the growth stage, the flux
of acetyl-CoA generated by pyruvate was 1.22 mmol
gDW−1 h−1, while this value was 1.56 mmol gDW−1 h−1
during the product synthesis stage. This corresponds to a
27.87% increase, which would ensure acetyl-CoA was
available for ARA production due to the enhanced activityacyl-carrier protein, acacp: Acetyl-[acyl-carrier protein], malcoa: malonyl-CoA,
oyl-[acp], c4dacp: but-2-enoyl-[acp], c40acp: butanoyl-[acp], c6oacp:
cp], c60acp: hexanoyl-[acp], c8oacp: 3-oxooctanoyl-[acp], c8hacp:
0oacp: 3-oxodecanoyl-[acp], c10hacp: 3-hydroxydecanoyl-[acp], c10dacp:
c12hacp: 3-hydroxy-dodecanoyl-[acp], c12dacp: dodec-2-enoyl-[acp],
2-enoyl-[acp], c14hacp: 3-hydroxymyristoyl-[acp], c140acp: myristoyl-[acp],
6dacp: hexadec-2-enoyl-[acp], c160acp: hexadecanoyl-[acp], c160:
oa: octadecenoyl-CoA, c182coa: linoleoyl-CoA, c183(6)coa: gamma-
yl-CoA, c204(6): ARA, c183(3)coa: alpha-Linolenoyl-CoA, c184(3)coa:
osapentaenoyl-CoA, c225(3)coa: (7Z,10Z,13Z,16Z,19Z)-Docosapentaenoyl-
6Z,9Z,12Z,15Z,18Z,21Z)-Tetracosahexaenoyl-CoA,
Figure 4 The sources of acetyl-CoA in M. alpina. (cit: citrate, ac: acetate, llac: l-lactate, mal: malate, pep: phosphoenolpyruvate, pyr: pyruvate,
accoa: acrtyl-CoA, asp: l-aspartate, bala: beta-alanine, oppa: 3-oxopropanoate, ile: l-isoleucine, omval: (s)-3-nethyl-2-oxopentanoate, mbcoa:
2-methylbutanoyl-CoA, mcrocoa: 2-methylcrotonoyl-CoA, metbycoa: (2S,3S)-3-Hydroxy-2-methylbutanoyl-CoA, mcecoa: 2-Methylacetoacetyl-CoA,
lys: l-lysine, sacp: l-saccharopine, amasa: l-2-aminoadipate 6-semialdehyde, ama: l-2-aminoadipate, aka: 2-oxoadipate, gltcoa: glutaryl-CoA, c4dcoa:
crotonoyl-coa, c4hcoa: (S)-3-Hydroxybutanoyl-CoA, aaccoa: acetoacetyl-CoA, leu: l-leucine, 4mop: 4-methyl-2-oxopentanoate, ivacoa: 3-isovaleryl-coa,
mcrcoa: 3-nethylcrotonyl-CoA, mgcoa: trans-3-methylglutaconyl-CoA, hmgcoa: (s)-3-hydroxy-3-methylglutaryl-coa).
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2.3.1.12, 1.8.1.4) [37]. Although aspartate, isoleucine,
leucine, and lysine could all be used to generate acetyl-
CoA for ARA production. Asparate has four carbon, while
isoleucine, leucine, and lysine all contains six carbon.
When the maximum uptake rate of asparate and the other
amino acids were set at 0.15 mmol gDW−1 h−1 and
0.1 mmol gDW−1 h−1, respectively. FBA showed only
that leucine and lysine could increase ARA production
by 14.06% and 13.28%.
In model iCY1106, acetyl-CoA can be consumed by
amino acid synthesis, amino sugar metabolism and fatty
acid synthesis as well as ARA production (Additional
file 5b). During the synthesis of six amino acids (threo-
nine, methionine, lysine, cysteine, ornithine, and leucine),
acetyl-CoA was required. FBA results showed that during
the growth stage, 96.5% of the acetyl-CoA flux was used
to synthesize fatty acids and 2.58% was used for amino
acid synthesis. In contrast, during the product synthesis
stage, the flux of acetyl-CoA used for fatty acid synthesis
accounted for 99.52%, which indicates that amino acid
synthesis was inhibited during ARA production. Limiting
the nitrogen source can be an effective strategy to control
amino acids biosynthesis [38], in which the lipid yield may
be increased despite decreases in mycelia concentration.
During the growth stages, the flux of acetyl-CoA
used to synthesize malonyl-CoA, catalyzed by acetyl-
CoA carboxylase (ACC, EC 6.4.1.2), was 0.79 mmol
gDW−1 h−1. In contrast during the ARA productionstage, the corresponding flux was 1.43 mmol gDW−1 h−1
(81.0%). ACC catalyzes the first committal step of the fatty
acid biosynthetic pathway, and should be overexpressed to
maximize ARA production [39]. Glutamate has been
shown to activate ACC, and adding glutamate to the cul-
ture medium led to an increase in total lipid (21.81%) and
ARA yield (66.07%) [40]. As the M. alpina growth rate
in batch culture ranged from 0.06 h−1 to 0.19 h-1
[1,7,8,41,42], the glutamate uptake rates used for the in
silico analysis should be set between 0 and 1.8 mmol
gDW−1 h−1. When the glutamate uptake rate was in-
creased, ARA production increased from 0.128 mmol
gDW−1 h−1 to 0.355 mmol gDW−1 h−1 (Additional file 5c).
During PUFA biosynthesis, NADPH is a necessary
cofactor for de novo fatty acid synthesis involving de-
saturation and elongation. In model iCY1106, there
were 172 reactions involving NADPH (Additional file 6).
With ARA production fixed at 0.059 mmol gDW−1 h−1
(μ = 0.06 h−1) and 0.128 mmol gDW−1 h−1 (μ = 0.03 h−1),
the flux of NADPH reactions were investigated. In total,
53 NADPH reactions exhibited flux changes of > 10−6 mmol
gDW−1 h−1 (Figure 5).
Further research showed that only five reactions (R2,
R3, R4, R5, and R6) involving accumulation of NADPH
were significantly altered. When ARA production was
increased, three reactions (R4, R5, and R6) underwent
flux increases, which corresponded to enhanced enzyme
activities due to up-regulation of the genes encoding the
enzymes. Of these, malic enzyme (ME, EC 1.1.1.40),
Figure 5 Changes of reactions involving NADPH at different ARA levels. (Different colors represent different changes on NADPH flux. Flux obviously
changed reactions are listed. R2: D-glucose 6-phosphate + NADP⬄ 6-phospho-D-glucono-1,5-lactone + NADPH + H, R3: 6-phospho-D-gluconate +
NADP - > D-ribulose 5-phosphate + CO2 + NADPH+H, R4: (S)-malate + NADP - > pyruvate + CO2 + NADPH, R5: L-glutamate 5-semialdehyde + NAD
P+ H2O - > L-glutamate + NADPH+ H, R6: 1-pyrroline-5-carboxylate + NADPH+ H⬄ L-proline + NADP, R16: Nitrite + 3 NADPH + 5 H - > Ammonia + 3
NADP + 2 H2O, R51: N-acetyl-L-glutamyl 5-phosphate + NADPH+ H⬄ N-acetyl-L-glutamate 5-semialdehyde + NADP + Phosphate, R53: (S)-3-hydroxy-
3-methylglutaryl-CoA + 2 NADPH+ 2 H⬄ (R)-mevalonate + CoA + 2 NADP).
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(R4), is considered a key enzyme in lipogenesis in M.
alpina. ME expression and enzyme activity are enhanced
during ARA production [43], and the minimization of
metabolic adjustment (MOMA) method was used to in-
vestigate the role of this enzyme. With the biomass and
ARA flux maximized by ME deletion using MOMA, 410
(22.11%) reactions showed flux changes (Additional file 6)
compared with the wild type model. The ARA exchange
reaction flux was lowered from 0.128 mmol gDW−1 h−1 to
0.079 mmol gDW−1 h−1, a decrease of 38.28%. Addition-
ally, all reactions involving NADPH consumption reac-
tions other than R13, R16, R51, and R53 were associated
with lipid metabolism. These results indicated that the in-
crease in ARA production was directly correlated with the
NADPH consumption rate.Conclusions
In this study, a genome-scale metabolic model (iCY1106)
for Mortierella alpina ATCC 32222 was successfully re-
constructed using knowledge from the scientific literature
and publicly accessible databases. The model comprised
1106 genes, 1854 reactions and 1732 metabolites, andincluded 247 transport reactions and 216 exchange re-
actions. Following a series of simulations and verifica-
tion by measurement of growth rates and substrate
usage, the model was found to agree with published lit-
erature. The model was used to investigate the effects
of the important precursors acetyl-CoA and NADPH
on the biosynthesis of PUFAs such as ARA and EPA.
FBA results showed that enhancing the pyruvate de-
hydrogenase complex increased acetyl-CoA availability
for increasing ARA production. Limiting the nitrogen
source was an effective method for reducing acetyl-CoA
consumption, and malic enzyme was found to be a key
node in the regulation of NADPH in ARA biosynthesis.
Model iCY1106 could serve as a useful predictive tool for
future systems biology studies to guide the genetic engin-
eering of M. alpina to improve the production of industri-
ally important metabolites.Methods
Construction of the M. alpina GSMM
The draft model was constructed by amassing reactions
from the genome-scale metabolic models of genetically
related organisms Aspergillus terreus [44], Pichia pastoris
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based on orthologs shared between M. alpina and the
three reference organisms identified by protein sequence
similarity searches using BLAST. Protein sequences from
A. terreus NIH 2624, P. pastoris GS 115 and Y. lipolytica
CLIB 122 were downloaded from UniProt [46]. Open read-
ing frame (ORF) information for M. alpina ATCC 32222
was provided by Yong Q. Chen based on sequencing
results. The iJL1454 GSMM was used as a reference.
Additionally, iLC915 [45] and iYL619_PCP [20] were
also used for comparison since both models were con-
cerned with lipid metabolism and overproduction. To
ensure accuracy, only sufficiently similar orthologs with e-
values ≤10−30 and sequence identities ≥40% were included
[47]. To expand and update the draft model, the genome
of M. alpina was re-annotated by submitting ORFs to the
KAAS online annotation server [48]. Metabolic reactions
absent from the draft model were added from the KEGG
database [49] based on KAAS annotation results. MetaCyc
[50] and BioPath [51] databases were used to judge re-
action reversibility. Compartmentalization information
assigned to reactions was determined by subcellular
localization prediction tools CELLO [52] and WoLF
PSORT. [53] BaCelLo [54] was also used for proteins
that were difficult to determine with the other tools.
Transport information was obtained by cross-referencing
BLATSp searches and the Transporter Classification Data-
base TCDB [55].
To refine the draft model, the gapFind [56] program
in the COBRA Toolbox [22] was used to identify meta-
bolic gaps in draft model and literature data were used
to fill these gaps. The metabolites in each reaction were
characterized based on their chemical formulae and neu-
tral charges, which were obtained using CHEBI [57] and
PubChem [58].
Biomass composition
The biomass equation of M. alpina was assumed to have
six components: proteins, DNA, RNA, lipids, the cell wall
and the small molecule pool [59,60]. Since no detailed in-
formation on M. alpina DNA and RNA was available, the
ratio was assumed to be the same as in the related Asper-
gillus niger [61]. The nucleotide and amino acid compos-
ition were calculated based on the M. alpina ATCC 32222
genome [2], as no specific experimental data were avail-
able. Similarly, the cell wall composition was calculated
based on the typical fungal cell wall structure [62]. The
lipid composition was calculated based on the current
literature [63]. For calculation of energetic parameters,
the growth and non-growth associated ATP maintenance
values (GAM and NGAM, respectively) were assumed to
be the same as those in the central carbon metabolic
model of A. niger [64]. Detailed biomass composition in-
formation can be found in Additional file 7.Simulation and analysis
The reconstructed metabolic network was converted
into stoichiometric matrix (S = M * N) using the Matlab
program, where M represents metabolites and N repre-
sents reactions [65]. The basic tools used for model ana-
lysis were flux balance analysis (FBA) and flux variability
analysis (FVA). GLPK was used for linear programming
[22], and Gurobi was used for quadratic programming
[66]. In silico analysis included growth simulation, gene
and reaction essentiality analysis, robustness analysis, and
minimization of metabolic adjustment. Analyses were per-
formed according to the instructions for the COBRA
Toolbox [22]. Constraints used in each analysis are men-
tioned in the results section. To analyze model parameters
relevant to cell growth, the biomass equation was selected
as the objective function. For analysis of ARA production,
the exchange reaction of ARA was the objective function.
Additional files
Additional file 1: Detailed information about model iCY1106.
Additional file 2: Shared reactions between Vongsangnak’s model
and iCY1106 (not including transport and exchange reactions, no
compartments information).
Additional file 3: Result of essential genes identified by FBA using
minimum growth medium and yeast extract medium.
Additional file 4: Simulation result for the capability of usage
different carbon and nitrogen sources for iCY1106.
Additional file 5: a Figure for the robustness analysis about oxygen
and ARA. b Figure about the acetyl-CoA consumption pathways in
iCY1106. c Figure for the robustness analysis about glutamate and ARA.
Additional file 6: FBA simulation result for the reactions involving
NADPH at different ARA levels.
Additional file 7: Biomass composition information for M. alpina.
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